We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$27.3B
AUM Growth
-$28.2B
(-51%)
Cap. Flow
-$28.9B
Cap. Flow
% of AUM
-105.88%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
1,354
New
88
Increased
57
Reduced
1,096
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$36.3M |
| 2 |
Paycom
PAYC
|
+$30.3M |
| 3 |
Airbnb
ABNB
|
+$26.2M |
| 4 |
Charles River Laboratories
CRL
|
+$22.6M |
| 5 |
Bio-Techne
TECH
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Amazon
AMZN
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$1.01B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$881M |
| 5 |
Comcast
CMCSA
|
+$482M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.21% |
| 2 | Healthcare | 16.15% |
| 3 | Financials | 15.41% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Exponent
EXPO
$3.19B
| $45K | ﹤0.01% |
397
-4,437
| -92% | -$479K |
|
1202
Ethan Allen Interiors
ETD
$600M
| $44K | ﹤0.01% |
1,874
-28,372
| -94% | -$700K |
|
|
HBI
1203
DELISTED
Hanesbrands
HBI
| $44K | ﹤0.01% |
2,580
-2,580
| -50% | -$48.4K |
|
1204
ABM Industries
ABM
$2.89B
| $42K | ﹤0.01% |
+944
| New | +$43.7K |
|
|
CTG
1205
DELISTED
Computer Task Group, Inc.
CTG
| $42K | ﹤0.01% |
5,258
-5,258
| -50% | -$46.2K |
|
|
FRGI
1206
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $42K | ﹤0.01% |
3,789
-3,789
| -50% | -$47.6K |
|
|
CTIC
1207
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $42K | ﹤0.01% |
14,325
-45,569
| -76% | -$124K |
|
1208
Civeo
CVEO
$356M
| $41K | ﹤0.01% |
1,824
-1,824
| -50% | -$39.5K |
|
1209
Sturm, Ruger & Co
RGR
$603M
| $41K | ﹤0.01% |
550
-550
| -50% | -$42.8K |
|
|
BCPC
1210
Balchem Corp
BCPC
$5.26B
| $41K | ﹤0.01% |
+285
| New | +$38.6K |
|
|
CCRN
1211
DELISTED
Cross Country Healthcare
CCRN
| $40K | ﹤0.01% |
1,882
-1,882
| -50% | -$35.3K |
|
1212
Daktronics
DAKT
$946M
| $40K | ﹤0.01% |
7,393
-7,393
| -50% | -$43.9K |
|
|
SPR
1213
DELISTED
Spirit AeroSystems
SPR
| $40K | ﹤0.01% |
900
-900
| -50% | -$37.7K |
|
1214
Myriad Genetics
MYGN
$476M
| $37K | ﹤0.01% |
1,153
-30,251
| -96% | -$1M |
|
|
ONIT
1215
Onity Group
ONIT
$342M
| $37K | ﹤0.01% |
1,301
-12,779
| -91% | -$353K |
|
1216
Seres Therapeutics
MCRB
$45M
| $36K | ﹤0.01% |
262
-302
| -54% | -$59.1K |
|
1217
Buckle
BKE
$2.32B
| $35K | ﹤0.01% |
894
-894
| -50% | -$38.1K |
|
1218
East-West Bancorp
EWBC
$17.8B
| $35K | ﹤0.01% |
453
-9,217
| -95% | -$671K |
|
|
DSPG
1219
DELISTED
DSP Group Inc
DSPG
| $35K | ﹤0.01% |
+1,603
| New | +$28.6K |
|
1220
Lincoln Educational Services
LINC
$1.38B
| $34K | ﹤0.01% |
5,114
-5,114
| -50% | -$34.2K |
|
|
NVTA
1221
DELISTED
Invitae Corporation
NVTA
| $34K | ﹤0.01% |
1,200
-1,200
| -50% | -$35.2K |
|
1222
Stewart Information Services
STC
$2.14B
| $33K | ﹤0.01% |
527
-527
| -50% | -$31.4K |
|
1223
Kohl's
KSS
$2.16B
| $31K | ﹤0.01% |
660
-660
| -50% | -$35.3K |
|
1224
Boyd Gaming
BYD
$6.75B
| $30K | ﹤0.01% |
469
-469
| -50% | -$27.8K |
|
1225
City Holding Co
CHCO
$2.05B
| $30K | ﹤0.01% |
+390
| New | +$29.6K |
|
Similar funds
HF
KBC Group's Q3 2021 Portfolio in Review
As of Q3 2021, KBC Group held 1,354 positions worth $27.3B, down 51% from $55.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
KBC Group withdrew a net $28.9B in Q3 2021, closing 66 positions and reducing 1,096 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $42.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in DoorDash worth $9.43M.
- KBC Group's largest Q3 2021 buy was DoorDash: 45,764 shares worth $9.43M.
- KBC Group added most to Zscaler in Q3 2021, an estimated $36.3M increase.
- KBC Group's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.57B.
- KBC Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $42.6M.
- KBC Group's ten largest holdings make up 23% of its $27.3B portfolio in Q3 2021.
- KBC Group opened 88 new positions and closed 66 in Q3 2021.
- KBC Group's portfolio value fell 51% quarter-over-quarter to $27.3B.
Based on KBC Group's 13F filing for Q3 2021, filed 10 Nov 2021.